1. Home
  2. DRIO vs BOLD Comparison

DRIO vs BOLD Comparison

Compare DRIO & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRIO
  • BOLD
  • Stock Information
  • Founded
  • DRIO 2011
  • BOLD 2018
  • Country
  • DRIO United States
  • BOLD United States
  • Employees
  • DRIO N/A
  • BOLD N/A
  • Industry
  • DRIO Medical/Dental Instruments
  • BOLD
  • Sector
  • DRIO Health Care
  • BOLD
  • Exchange
  • DRIO Nasdaq
  • BOLD Nasdaq
  • Market Cap
  • DRIO 30.5M
  • BOLD 30.3M
  • IPO Year
  • DRIO N/A
  • BOLD 2024
  • Fundamental
  • Price
  • DRIO $0.72
  • BOLD $1.16
  • Analyst Decision
  • DRIO Strong Buy
  • BOLD Buy
  • Analyst Count
  • DRIO 2
  • BOLD 3
  • Target Price
  • DRIO $2.50
  • BOLD $4.00
  • AVG Volume (30 Days)
  • DRIO 129.3K
  • BOLD 351.6K
  • Earning Date
  • DRIO 08-07-2025
  • BOLD 08-11-2025
  • Dividend Yield
  • DRIO N/A
  • BOLD N/A
  • EPS Growth
  • DRIO N/A
  • BOLD N/A
  • EPS
  • DRIO N/A
  • BOLD N/A
  • Revenue
  • DRIO $28,034,000.00
  • BOLD N/A
  • Revenue This Year
  • DRIO $13.66
  • BOLD N/A
  • Revenue Next Year
  • DRIO $24.50
  • BOLD N/A
  • P/E Ratio
  • DRIO N/A
  • BOLD N/A
  • Revenue Growth
  • DRIO 47.20
  • BOLD N/A
  • 52 Week Low
  • DRIO $0.50
  • BOLD $1.00
  • 52 Week High
  • DRIO $1.55
  • BOLD $4.72
  • Technical
  • Relative Strength Index (RSI)
  • DRIO 50.61
  • BOLD N/A
  • Support Level
  • DRIO $0.67
  • BOLD N/A
  • Resistance Level
  • DRIO $0.72
  • BOLD N/A
  • Average True Range (ATR)
  • DRIO 0.03
  • BOLD 0.00
  • MACD
  • DRIO 0.00
  • BOLD 0.00
  • Stochastic Oscillator
  • DRIO 48.31
  • BOLD 0.00

About DRIO DarioHealth Corp.

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

Share on Social Networks: